Related Articles
Intravesical treatment of chemotherapeutic agents sensitizes bacillus Calmette‑Guerin by the modulation of the tumor immune environment
Comparison of intravesical bacillus Calmette‑Guerin and mitomycin C administration for non‑muscle invasive bladder cancer: A meta‑analysis and systematic review
Antibacterial activity of adriamycin against bacillus Calmette-Guerin
Bacillus Calmette-Guerin (BCG) in the treatment of superficial bladder cancer
Pyuria predicts poor prognosis in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin